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Abstract
Mycobacterium tuberculosis (Mtb) and helminth infections elicit antagonistic immune effec-
tor functions and are co-endemic in several regions of the world. We therefore hypothesized
that helminth infection may influence Mtb-specific T-cell immune responses. We evaluated
the cytokine profile of Mtb-specific T cells in 72 individuals with pulmonary TB disease
recruited from two Sub-Saharan regions with high and moderate helminth burden i.e. 55
from Tanzania (TZ) and 17 from South Africa (SA), respectively. We showed that Mtb-spe-
cific CD4 T-cell functional profile of TB patients from Tanzania are primarily composed of
polyfunctional Th1 and Th2 cells, associated with increased expression of Gata-3 and
reduced expression of T-bet in memory CD4 T cells. In contrast, the cytokine profile of Mtb-
specific CD4 T cells of TB patients from SA was dominated by single IFN-γ and dual IFN-γ/
TNF-α and associated with TB-induced systemic inflammation and elevated serum levels of
type I IFNs. Of note, the proportion of patients with Mtb-specific CD8 T cells was significantly
reduced in Mtb/helminth co-infected patients from TZ. It is likely that the underlying helminth
infection and possibly genetic and other unknown environmental factors may have caused
the induction of mixed Th1/Th2 Mtb-specific CD4 T cell responses in patients from TZ.
Taken together, these results indicate that the generation of Mtb-specific CD4 and CD8 T
cell responses may be substantially influenced by environmental factors in vivo. These
observations may have major impact in the identification of immune biomarkers of disease
status and correlates of protection.
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Author summary
Mycobacterium tuberculosis (Mtb) and helminth infections are co-endemic in several
regions of the world and their immune responses may be mutually antagonistic. We there-
fore hypothesized that helminth infection would impact and potentially shape Mtb-specific
T-cell responses and systemic inflammation in patients suffering from active pulmonary
tuberculosis (TB) enrolled from two helminth endemic regions i.e. Tanzania (TZ) and
South Africa (SA). In this study, we demonstrate for the first time that TB patients from SA
and TZ harbor distinct immune responses to Mtb antigens. Indeed, we showed that Mtb-
specific CD4 T-cell responses of TB patients from TZ were composed by a mixed T helper
type 1 (Th1) and Th2 responses. In contrast, the cytokine profile of Mtb-specific CD4 T
cells of TB patients from SA was dominated by Th1 cells and associated with TB-induced
systemic inflammation and elevated serum levels of type I IFN. Taken together, these data
indicate that Mtb-specific T-cell responses are diverse in human populations and can be
strongly influenced by host and pathogen genetic background, co-infections and yet un-
known environmental factors. Identification of correlates of risk and protection from TB
disease will help in the rational development of protective T-cell based vaccines against TB,
early monitoring TB treatment outcomes and focused follow up of high risk populations.
Introduction
Helminth infections are endemic in many African countries with different prevalence depend-
ing on the geographic region helminth species and age of population [1]. Soil transmitted hel-
minth infections are among the most common infections, transmitted via soil contaminated
by eggs excreted from human faeces [2]. Of note, helminth infections are co-endemic in many
geographic areas endemic for Mycobacterium tuberculosis (Mtb), HIV-1 and Plasmodium fal-
ciparum. Therefore, co-infections of helminths with Mtb, HIV-1 and/or Plasmodium falcipa-
rum occur in a large proportion of the subjects [3].
Mycobacterium tuberculosis (Mtb) is a facultative intracellular organism, obligate aerobe,
infecting primarily lungs via the aerogenic route [4]. It has been recently estimated that 1.7 bil-
lion people are infected with Mtb among which 5–15% will develop tuberculosis disease (TB)
[5]. To date, the only vaccine available to prevent TB disease consist of an attenuate strain of
M. bovis, the Bacillus of Calmette et Gue´rin (BCG). While BCG immunization protects from
life-threatening disseminated forms of TB disease in children, its efficacy in adults is inconsis-
tent [6]. The protective components of Mtb-specific immunity are partially defined. Several
studies have underscored the essential role of IL-12/IFN-γ axis in the protection against Mtb
infection [7–10]. In addition, an efficient CD4 T-cell response probably associated with type 1
cytokine secretion is associated with the control of Mtb infection, since a severe reduction in
the CD4 T cell number during HIV infection or the suppression of their function following
anti-TNF-α therapy are associated with increased risk of TB reactivation [11, 12].
The current paradigm of human cellular immunity indicates that functionally-distinct CD4
T-cell populations are specifically involved against a variety of pathogens depending on their
size and their intra- or extra-cellular localization. In this model, type 1 helper CD4 T cells (Th1
cells) intervene against viruses and intracellular pathogens, Th2 cells against parasites such as
worms and Th17 cells against extracellular pathogens [13, 14] including bacteria and fungi
[14, 15]. Consistent with this paradigm, the protective Mtb-specific T-cell response is usually
ascribed to typical Th1 response with CD4 T cells producing cytokines such as IFN-γ or TNF-
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α that contribute to the recruitment of monocytes and granulocytes and activate the anti-
microbial activity of macrophages [16, 17]. By contrast, helminth infections induce IL-4/IL-5
and IL-13 producing CD4 T cells and regulatory T cells [18–21] associated with the alternative
activation of macrophages for repair of tissues injured upon migration of worms across differ-
ent body compartments [1]. With regard to the generation of the functionally distinct T helper
CD4 T cell populations, the pioneering studies from Romagnani and others [22, 23], clearly
demonstrated the critical importance of the cytokine environment, rather than the specific
antigen in the development of distinct T helper antigen-specific CD4 T cells [24, 25]. In this
regard, the presence of an IL-4 cytokine background favored the development of Th2 specific
to pathogens that usually induce the classical Th1 responses [23, 26].
Multiple studies performed in Mtb/helminth co-infected individuals have focused on the
impact of helminth infection on 1) TB diagnosis [27–35], 2) reactivation of TB from latently
infected individuals (LTBI) [36, 37] and 3) BCG vaccine immunogenicity [38–40]. In addition,
it was recently shown that helminth infection may interfere and/or influence innate [41], cellu-
lar [42–44] and humoral [45] immune responses to Mtb. However limited information is avail-
able on the cytokine profile of Mtb-specific T-cell immune responses in subjects with Mtb/
helminth co-infection.
In the present study, we investigated the cytokine profile of Mtb-specific immune response
in patients with clinically active TB from two countries i.e. Tanzania (TZ) and South Africa
(SA) in the presence or absence of active helminth infections. We provide evidence that the
functional profile of Mtb-specific CD4 T cells of TB patients from TZ was characterized by a
mixed Th1/Th2 cytokine profile, while that from SA was associated with a typical single IFN-γ
and dual IFN-γ/TNF-α Th1 profile.
These results demonstrate that distinct functional profiles of CD4 T-cell responses can be
directed against the same pathogen, i.e. Mtb, in human populations from different geographic
areas. Ad hoc designed studies will be needed to define the factors driving the distinct func-
tional profiles as well as to determine whether the distinct functional profiles are associated
with variation of the TB pathology and/or response to drug therapy.
Results
The aims of the present study were i) to delineate Mtb-specific T-cell responses in patients
with pulmonary tuberculosis (TB) and helminth co-infection from two Sub-Saharan countries,
e.g. Tanzania (TZ) and South Africa (SA) and ii) to determine the influence of ongoing or past
helminth infections on Mtb-specific T-cells responses. Therefore, we analyzed the cytokine
profile and cell lineage T cell transcription factor expression in Mtb-specific CD4 T cells and
serum cytokine levels in 72 individuals (Table 1). The patients were screened for active hel-
minth infections and/or previous exposure to helminths and the cohort stratified into three
groups: 1) active TB patients from SA with no sign of active helminth infections, 2) active TB
patients from TZ with no sign of active helminth infections and 3) active TB patients co-
infected with helminths from TZ (see flow chart, S1 Fig).
Table 1. Demographic and clinical data.
ID Origin Number Mean Age Gender Helminth infection BCG vaccination status
TB SA South Africa 17 36 3F/12M 11% past exposure 17/17 (100%)
TB TZ Tanzania 25 29 9F/16M 28% past exposure 25/25 (100%)
Mtb/helminthTZ Tanzania 30 30 6F/24M Ongoing 30/30 (100%)
https://doi.org/10.1371/journal.pntd.0005817.t001
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Mtb-specific CD4 T cells from TB patients from TZ have mixed Th1/Th2
cytokine profile
The functional profiles of Mtb-specific CD4 T-cell responses were assessed by intracellular
cytokine staining (ICS) according to the gating strategy shown in S2 Fig. In particular, the abil-
ity of Mtb-specific CD4 T cells to produce IFN-γ, TNF-α, IL-2, IL-4, IL-5 and/or IL-13 in
response to ESAT-6 and CFP-10 peptide pools stimulation was assessed by multi-parametric
flow cytometry in 25 TB patients and 30 Mtb/helminth co-infected patients from TZ and com-
pared to 17 TB patients from SA. Of note, Th2 cytokines i.e. IL-4, IL-5 and IL-13 were all
assessed in the same flow cytometry fluorescence channel, which allowed the assessment of
total Th2 cytokine production but prevented direct identification of individual IL-4, IL-5 or
IL-13 Mtb-specific CD4 T-cell responses. Cytokine profiles of Mtb-specific CD4 T cells from
three representative TB patients from SA (#08) and TZ (TB (#60062) and Mtb/helminth co-
infected patient (#60031) are shown in Fig 1A. We first compared the frequencies of cytokine-
producing Mtb-specific memory CD4 T cells from TB patients from SA versus TB patients
from TZ (Fig 1B). The cumulative data showed a significantly higher IL-2+ and IL-4/IL-5/IL-
13+ Mtb-specific memory CD4 T-cell frequencies in TB patients from TZ compared with TB
patients from SA (P<0.05), while the frequencies of IFN-γ and TNF-α producing Mtb-specific
memory CD4 T cells were not significantly different between TB patients from TZ and from
SA (P>0.05; Fig 1B). Interestingly, no significant differences were observed for Th1 and Th2
cytokine producing CD4 T cells between TB patients from TZ with and without ongoing hel-
minth co-infections (P>0.05) (Fig 1B).
We next analyzed the cytokine profile of Mtb-specific memory CD4 T cells of TB patients
from SA and TZ (Fig 1C, pie charts). The cytokine profile of Mtb-specific memory CD4 T cells
of TB patients from SA was significantly different from of TB patients from TZ (P<0.05; Fig
1C, pie charts). Again, no significant differences were observed between TB patients and Mtb/
helminth co-infected patients from TZ (P>0.05) (Fig 1C, pie charts). In depth analysis showed
that Mtb-specific CD4 T-cell responses of TB patients from TZ were significantly enriched in
polyfunctional IFN-γ+IL-2+TNF-α+IL-4/5/13- CD4 T cells (triple IFN-γ/IL-2/TNF-αMtb-spe-
cific CD4 T cells) and in IFN-γ-IL-2-TNF-α-IL-4/5/13+ CD4 T-cell populations (single IL-4/5/
13 Mtb-specific CD4 T cells) as compared to TB patients from SA (43–42% versus 20% for tri-
ple IFN-γ/IL-2/TNF-α and 14–16% versus 1% for single IL-4/5/13; P<0.05) (Fig 1C). In con-
trast, Mtb-specific CD4 T-cell responses of TB patients from SA were significantly enriched
in IFN-γ+IL-2-TNF-α+IL-4/5/13- (dual IFN-γ/TNF-αMtb-specific CD4 T cells) and in IFN-
γ+IL-2-TNF-α-IL-4/5/13- CD4 T-cell populations (single IFN-γMtb-specific CD4 T cells) as
compared to TB patients from TZ (about 45% versus 20–18% for dual IFN-γ/TNF-α and 25%
versus 7–4% for single IFN-γ+; P<0.05) (Fig 1C). No significant differences were observed
between the Mtb-specific CD4 T-cell cytokine profile of TB patients and Mtb/helminth co-
infected patients from TZ (P>0.05) (Fig 1C). Of note, Schistosoma mansoni-specific CD4 T-
cell responses were evaluated on Mtb/helminth co-infected individuals from TZ using S. man-
soni soluble egg antigens (SEA) by polychromatic flow cytometry (n = 7). The results obtained
showed that SEA-specific CD4 T-cell responses were dominated by single TNF-α and single
IL-4/IL-5/IL-13-producing CD4 T cells, while polyfunctional IFN-γ+IL-2+TNF-α+ CD4 T
cells represented less than 5% of total SEA-specific CD4 T-cell responses confirming previous
observations [46, 47] (S3 Fig).
To better estimate the influence of 1) different helminth species, 2) infection caused by
more than one helminth (polyparasitism), 3) differences in helminth lung migration capacity
and 4) past helminth exposure on the generation of Th2 Mtb-specific CD4 T-cells, the propor-
tion of IL-4/5/13-producing Mtb-specific CD4 T cells was compared between TB patients
Mixed Th1 and Th2 Mtb-specific CD4 T cells in active TB patient
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0005817 July 31, 2017 4 / 26
Fig 1. Mtb-specific CD4 T cells from TB patients from TZ have mixed Th1/Th2 cytokine profile. (A) Representative flow cytometry
profile of Mtb-specific CD4 T cells producing IFN-γ, IL-4/5/13, TNF-α and/or IL-2 of one TB patient from SA (#08), one TB patients from TZ
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from TZ with helminth infection caused by one or more helminth species (S4A Fig), or
between TB patients from TZ coinfected with helminth species exhibiting (hookworms and
Strongyloides stercoralis) or not (S. mansoni, Schistosoma haematobium and Wuchereria ban-
crofti) lung migration capacity (S4B Fig). Similarly, the proportion of IL-4/5/13-producing
Mtb-specific CD4 T cells was compared between TB patients from SA or TZ with evidence of
past exposure to helminths versus TB patients with no sign of ongoing or past exposure to hel-
minths (S4C and S4D Fig). The cumulative data showed that the proportion of single IL-4/5/
13-producing Mtb-specific CD4 T cells from active TB cases was not influenced by 1) polypar-
asitism (including W. bancrofti, hookworm, S. mansoni, S. haematobium or S. stercoralis)
(P>0.05) (S4A Fig), 2) by helminth infections caused by helminth species exhibiting lung
migration capacity, or 3) by past exposure to helminths (S4B and S4C Fig).
To further characterize the cytokine profile of Mtb-specific T-cells, multiplex bead array
analyses (luminex) were performed on supernatants of ESAT-6/CFP-10 peptide pool (Mtb)-
stimulated cell cultures. The cumulative data showed that Mtb-stimulated cell culture superna-
tants of TB patients from TZ secreted similar levels of IFN-γ, TNF-α and IL-10 (P>0.05), but
significantly higher levels of IL-2, IL-4, IL-5, IL-13, IL-17A and IL-17F than Mtb-stimulated
cell culture supernatants of TB patients from SA (P<0.05; Fig 1D). However, no significant dif-
ferences were observed between TB patients and Mtb/helminth co-infected patients from TZ
(P>0.05; Fig 1D), confirming our flow cytometry analyses. In addition, the levels of Th2 cyto-
kines secreted in Mtb-stimulated cell culture supernatants of Mtb/helminth patients from TZ
was not influenced by individual species of helminth infections, by polyparasitism (P>0.05)
(S4E Fig), by helminth species exhibiting lung migration capacity (S4F Fig), or by past expo-
sure to helminths (S4G and S4H Fig).
Taken together, our data indicate that a high proportion of Mtb-specific CD4 T cells from
Tanzanian TB patients have a mixed Th1/Th2 cytokine profile which is observed either in
patients with active helminth infection or in a large proportion of patients with positive hel-
minth serology. In contrast, Mtb-specific CD4 T cells from South African TB cases have a clas-
sical, previously described Th1 cytokine profile.
Memory CD4 T cells of TB patients from TZ harbor increased Gata-3
and reduced T-bet expression
We then determined whether the development of Mtb-specific Th2 CD4 T cells was associated
with changes in the expression of Th1 and Th2 cell lineage transcription factors, T-bet and
Gata-3 respectively [48, 49].
(#60062) and one Mtb/helminth co-infected patient from TZ (#60031). Cytokine profiles of CD4 T cells stimulated with SEB (positive
control) or left unstimulated (negative control) are also shown. (B) Percentage of Mtb-specific CD4 T cells producing TNF-α, IFN-γ, IL-2 or
IL-4/5/13 of TB patients from SA (n = 17), TB patients from TZ (n = 25) and Mtb/helminth co-infected patients from TZ (n = 30). (C)
Proportion of Mtb-specific CD4 T-cell responses producing IFN-γ, IL-4/5/13, TNF-α and/or IL-2 of TB patients from SA (n = 17), TB
patients from TZ (n = 25) and Mtb/helminth co-infected patients from TZ (n = 30). All the possible combinations of the responses are shown
on the x axis and the percentage of the functionally distinct cell populations within the Mtb-specific CD4 T-cell populations are shown on
the y axis. Responses are grouped and color-coded on the basis of the number of functions. The pie chart summarizes the data, and each
slice corresponds to the fraction of Mtb-specific CD4 T cell response with a given number of functions within the responding CD4 T-cell
population. Bars correspond to the fractions of different functionally distinct CD4 T-cell populations within the total CD4 T cells. Red arcs
correspond to IL-4/5/13-producing CD4 T-cell populations. (D) Levels of IFN-γ, TNF-α, IL-10, IL-2, IL-4, IL-5, IL-13, IL-17A and IL-17F
produced in Mtb-stimulated culture supernatants of TB patients from SA (n = 12), TB patients from TZ (n = 21) and Mtb/helminth co-
infected patients from TZ (n = 29) assessed by luminex assay. TB patients were color coded (B and D); TB patients from SA, blue; TB
patients from TZ, red and Mtb/helminth co-infected patients, green. Red stars indicate statistical significance. Statistical significance (* =
P<0.05) was calculated using one way Anova Kruskal-Wallis test followed by a Mann-Whitney test (B and D). Statistical analyses of the
global cytokine profiles (pie charts, C) were performed by partial permutation tests using the SPICE software as described [97].
https://doi.org/10.1371/journal.pntd.0005817.g001
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Representative examples and cumulative data showed that the percentage of memory CD4
T cells expressing Gata-3 was significantly increased in TB and Mtb/helminth co-infected
patients from TZ (7% and 7.9%, respectively) compared with TB patients from SA (2.4%;
P<0.05) (Fig 2A and 2B). In contrast, the percentage of memory CD4 T cells expressing high
levels of T-bet (T-bethigh) was significantly lower in TB and Mtb/helminth patients from TZ
(3.6% and 3.2%, respectively) as compared to TB patients from SA (12.3%; P<0.05) (Fig 2A
and 2C). However, the frequencies of memory CD4 T cells expressing Gata-3 or T-bethigh did
not differ between TB patients and Mtb/helminth co-infected patients from TZ (P>0.05) (Fig
2B and 2C). In addition, the frequency of memory CD4 T cells expressing Gata-3 of Mtb/hel-
minth co-infected patients from TZ was not influenced by the helminth species and by poly-
parasitism (P>0.05) (S4I Fig), by helminth species exhibiting lung migration capacity (S4J
Fig), or by past exposure to helminths (S4K and S4L Fig). Interestingly, the percentage of T-
bethigh memory CD4 T cells negatively correlated with the percentage of memory CD4 T cells
expressing Gata-3 (r = -0.6745; P<0.0001) (S5 Fig) thus supporting previous observations
[50].
We then determined whether the expression of T-bet or Gata-3 by memory CD4 T cells
was associated with Mtb-specific CD4 T-cell cytokine profile of TB patients and Mtb/hel-
minth co-infected patients from SA or TZ. To address this issue, we plotted the percentage of
Mtb-specific CD4 T cells producing IFN-γ or IL-4/5/13 against the percentage memory CD4
T cells expressing T-bethigh or Gata-3 from the same patients (Fig 2D and 2E). The cumula-
tive data showed that the percentage of IFN-γ-producing Mtb-specific CD4 T cells directly
correlated with the percentage of T-bethigh memory CD4 T cells (r = 0.3802, P = 0.0085)
(Fig 2D) and the percentage of IL-4/5/13-producing Mtb-specific CD4 T cells directly corre-
lated with the percentage of memory CD4 T cells expressing Gata-3 (r = 0.3782, P<0.0088)
(Fig 2E).
Taken together, these data indicate that TB patients from TZ have a mixed Th1/Th2 cyto-
kine profile associated with increased Gata-3 and reduced T-bethigh expression.
Reduced proportion of patients with detectable Mtb-specific CD8 T cells
in Mtb/helminth co-infected patients
Ongoing helminth infections has been shown to interfere with CD8 T cells responses targeting
viruses in mouse models [51, 52]. Our group and others has recently shown that Mtb-specific
CD8 T cells were more frequently detected in patients with TB disease as compared to those
with latent Mtb infection [53]. Based on this observation, a recent diagnostic test i.e. Quanti-
FERON TB PLUS proposes optimized CD8-TB-specific-peptides stimulation [54, 55]. This
prompted us to investigate whether ongoing helminth infections would influence the propor-
tion of TB patients with detectable Mtb-specific CD8 T cells. To address this issue, the ability
of Mtb-specific CD8 T cells to produce IFN-γ, TNF-α, IL-2 and perforin was assessed in 16 TB
patients and 23 Mtb/helminth co-infected patients from TZ by flow cytometry. As shown in
Fig 3A, the proportion of subjects with detectable Mtb-specific CD8 T cells was significantly
reduced in Mtb/helminth co-infected patients from TZ as compared to TB patients from TZ
(43.7% versus 80%, respectively; P<0.05; Fig 3A). The frequency of cytokine- and perforin-
producing Mtb-specific CD8 T cells and the functional profile of Mtb-specific CD8 T-cell
responses did not differ significantly between TB and Mtb/helminth co-infected patients from
TZ with detectable Mtb-specific CD8 T cells (Fig 3B) and the predominant CD8 T-cell popula-
tion was IFN-γ+IL-2-TNF-α+Perforin- (Fig 3C).
In summary, these data indicate that ongoing helminth infection reduced the proportion of
TB cases with detectable Mtb-specific CD8 T cells.
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Fig 2. Memory CD4 T cells of TB patients from TZ harbor increased Gata-3 and reduced T-bet expression. (A) Representative flow
cytometry profile of memory (CD45RA-) CD4 T cells (red dots) isolated from one TB patient from SA (#03), one TB patient (#60037) and one
Mtb/helminth co-infected patient (#60057) from TZ expressing Gata-3 and/or T-bet. Gates were set using naïve (CD45RA+) CD4 T cells and
CD8 T cells from each individual. Gata-3 and T-bet expression of individual CD8 T-cell are also shown (black dots). Percentage of memory
(CD45RA-) CD4 T cells isolated from TB patients from SA (n = 12), TB patients (n = 14) and Mtb/helminth co-infected patients (n = 13) from TZ
expressing Gata-3 (B) or T-bethigh (C). (D) Correlation between the percentage of IFN-γ-producing Mtb-specific CD4 T cells and the
percentage of memory CD4 T cells expressing T-bethigh of TB patients from SA (n = 12), TB (n = 14) and Mtb/helminth co-infected patients
from TZ (n = 13). (E) Correlation between the percentage of IL-4/5/13-producing Mtb-specific CD4 T cells and the percentage of memory CD4
T cells expressing Gata-3 of TB patients from SA (n = 12), TB (n = 14) and Mtb/helminth co-infected patients from TZ (n = 13). TB patients
were color coded (B-E); TB patients from SA, blue; TB patients from TZ, red and Mtb/helminth co-infected patients, green. Red stars indicate
statistical significance. Statistical significance (* = P<0.05) was calculated using one way Anova Kruskal-Wallis test followed by a Mann-
Whitney test (B and C) or Spearman rank test for correlation (D and E).
https://doi.org/10.1371/journal.pntd.0005817.g002
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Fig 3. Reduced proportion of patients with detectable Mtb-specific CD8 T cells in Mtb/helminth co-infected patients. (A) Proportion of TB
patients with detectable Mtb-specific CD8 T cells of TB and Mtb/helminth patients from TZ (n = 12 and 7, respectively). (B) Percentage of Mtb-specific
CD8 T-cell responses producing TNF-α, IFN-γ, IL-2 and/or perforin of TB patients (n = 12) and Mtb/helminth patients (n = 7) from TZ. TB patients were
color coded; TB patients from TZ, red and Mtb/helminth co-infected patients, green. (C) Functional profile of Mtb-specific CD8 T cells of TB patients and
Mtb/helminth co-infected patients from TZ. Red and green circles represent the proportion of Mtb-specific CD8 T cells producing TNF-α, IFN-γ, IL-2 and/or
perforin of TB and Mtb/helminth patients from TZ, respectively (C). Red arcs identify perforin producing cell populations (C). Red stars indicate statistical
significance (* = P<0.05). Statistical significance (P<0.05) was calculated using Chi square test (A) and Mann-Whitney test (B). Statistical analyses of the
global cytokine profiles (pie charts, C) were performed by partial permutation tests using the SPICE software as described [97].
https://doi.org/10.1371/journal.pntd.0005817.g003
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Differences in systemic inflammation markers in patients from TZ and
SA
One of the objectives of the present study was to determine whether ongoing helminth infec-
tion may influence the levels of systemic inflammation markers. In order to address this issue,
we first assessed the serum levels of IL-1α, IL-6, TNF-α, IL-10, IL-12p70, IFN-α2, IFN-β, IFN-
ω, IFN-γ, IL-23 and CRP of TB patients from TZ and SA by multiplex bead array analyses (Fig
4). The cumulative data indicated that the serum levels of IL-1α, TNF-α, IL-12p70, IFN-α2,
IFN-β, IFN-ω, IL-23 and CRP were significantly increased in TB patients from SA as compared
to TB patients from TZ (P<0.05) (Fig 4). However, the levels of IFN-γ, IL-6 and IL-10 were not
statistically different between TB patients from SA and TZ (P>0.05; Fig 4). Interestingly,
Fig 4. Differences in systemic inflammation markers in patients from TZ and SA. Serum levels of IL-1α, IL-6, TNF-
α, CRP, IL-12p70, IL-23, IL-10, IFN-α2, IFN-β, IFN-ω and IFN-γ of TB patients from SA (n = 15), TB and Mtb/helminth
co-infected patients from TZ (n = 25 and 30, respectively). TB patients were color coded; TB patients from SA, blue; TB
patients from TZ, red and Mtb/helminth co-infected patients, green. Red stars indicate statistical significance. Statistical
significance (* = P<0.05) was calculated using one way Anova Kruskal-Wallis test followed by a Mann–Whitney test.
https://doi.org/10.1371/journal.pntd.0005817.g004
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ongoing helminth infection did not further influence the serum levels of cytokines and CRP of
TB patients from TZ (P>0.05) (Fig 4).
Taken together, these data suggest that TB patients from SA and TZ showed differences in
serum cytokine profile. In comparison to Tanzanian TB cases, South African patients showed
a more pronounced pro-inflammatory serum cytokine profile associated with high levels of
type I IFNs.
Th1 cytokine profiles are associated with elevated systemic
inflammation markers
To better identify the immunological parameters associated with Mtb-specific immune signa-
ture in TB patients and the influence of ongoing helminth infection, a principal component
analysis (PCA) was performed. The results indicated that the Mtb-specific immune profile of
TB and Mtb/helminth co-infected patients from TZ clustered away from that of TB patients
from SA with a percentage of discrimination reaching about 70% (Fig 5A and 5B). In depth
analysis revealed that the differentially expressed immune parameters contributing the most to
discriminate Mtb-specific immune response of TB patients from TZ and SA were the percent-
ages of CD4 T cells expressing Gata-3 and T-bethigh, the proportion of polyfunctional TNF-α/
IFN-γ/IL-2, dual TNF-α/IFN-γ and single IFN-γMtb-specific CD4 T cells among total Mtb-
specific CD4 T-cell responses, levels of IL-5 in Mtb-stimulated culture supernatants and IFN-β
serum levels (Fig 5A and 5B and Table 2). Again, this analysis did not allow discriminating
Mtb-specific immune response of TB and Mtb/helminth patients from TZ (Fig 5A and 5B).
We next performed multiparametric statistical analysis to investigate the potential associa-
tions between the four major represented Mtb-specific CD4 T-cell populations i.e. triple IFN-
γ/IL-2/TNF-α, dual IFN-γ/TNF-α, single IFN-γ and single IL-4/5/13 Mtb-specific CD4 T cells,
the levels of cytokine detected in Mtb-stimulated culture supernatants, i.e. IL-2, IL-4, IL-5 and
IL-13, the percentages of memory CD4 T cells expressing Gata-3 or T-bethigh, and the serum
levels of IL-1α, TNF-α, IL-12p70, IFN-β and IL-23 in TB patients from SA and TZ (Fig 5C).
The combined data indicated that IFN-β serum concentrations positively correlated with i) T-
bethigh memory CD4 T cells, ii) higher proportion of Mtb-specific Th1 cells (single IFN-γ and
dual IFN-γ/TNF-α), iii) higher serum levels of pro-inflammatory cytokines (IL-1α and TNF-
α), IL-12p70 and IL-23 and negatively correlated with a) Gata-3 expression on memory CD4 T
cells, b) higher proportion of polyfunctional Mtb-specific CD4 T cells and c) type 2 cytokine
secretion (IL-5 and IL-13) (P<0.05) (Fig 5C).
Taken together, the data indicate that the serum cytokine profile and the Mtb-specific
immune signatures of TB patients from SA and TZ are significantly different and that Th1
cytokine profiles are positively associated with TB-induced systemic inflammation and higher
serum levels of type I IFNs.
Ongoing helminth infection is not associated with reduced anti-
mycobacterial treatment outcome
We then assessed the influence of ongoing helminth infection on TB drug treatment efficiency
in the Tanzanian cohort. To address this issue, we first assessed the presence of Mtb in the spu-
tum of treated individuals based on sputum smear microscopy. The cumulative data showed a
significant reduction in the proportion of patients with detectable Mtb in the sputum following
60 days of drug treatment (P<0.05; Fig 6A). The presence of an ongoing helminth infection
did not influence the effect of anti-mycobacterial drug treatment in relation to sputum detect-
able Mtb (P>0.05) (Fig 6A), suggesting that ongoing helminth infection was not associated
with reduced anti-mycobacterial treatment efficiency.
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In addition, 60 days of anti-mycobacterial treatment was associated with a significant
increase of the body mass index (BMI) and significant decrease of serum levels of CRP and
Fig 5. Th1 cytokine profiles are associated with elevated systemic inflammation markers. Principal component
analysis (PCA) of Mtb-specific immunity determined in TB patients from SA (n = 15), TB and Mtb/helminth co-infected
patients from TZ (n = 25 and 30, respectively). Blue, red and green symbols represent TB patients from SA, TB patients
from TZ, and Mtb/helminth co-infected patients, respectively. Blue, red and green ellipses represent clusters formed by
70% of TB patients from SA, TB patients and Mtb/helminth co-infected patients from TZ, respectively. Blue arrows
represent the differentially expressed immune parameters that significantly contributed (P<0.05) to discriminate Mtb-
specific immune signatures (A and B). (C) Correlogram of imputed Spearman-Rank-Correlation between the proportion
of triple IFN-γ/TNF-α/IL-2, dual IFN-γ/TNF-α, single IFN-γ and single IL-4/5/13 Mtb-specific CD4 T cells among total Mtb-
specific CD4 T-cell responses, levels of IL-2, IL-4, IL-5 and IL-13 detected in Mtb-stimulated culture supernatants,
percentages of memory CD4 T cells expressing Gata-3 or T-bethigh, serum levels of IL-1α, TNF-α, IL-12p70, IFN-β and
IL-23 determined in TB patients from SA and TZ (n = 70). Statistical significance was calculated using non parametric
test. Empty squares correspond to non significant correlations (P>0.05), blue circles indicate direct correlations and red
circles indicate inverse correlations (P<0.05). Blue and red circle sizes indicate statistical amplitude of correlation.
https://doi.org/10.1371/journal.pntd.0005817.g005
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pro-inflammatory cytokines i.e. IL-1α, IL-6, and IL-1β (P<0.05; Fig 6B–6D), irrespective of
the presence or absence of ongoing helminth infection (P>0.05) (Fig 6B–6D).
We next assessed the impact of TB treatment initiation on Mtb-specific T-cell immunity in
TB and Mtb/helminth patients. The functional profiles of Mtb-specific CD4 T-cell responses
and the transcription factor expression profiles were assessed using aforementioned experi-
mental strategies. The cumulative data indicated that the initiation of efficient TB treatment
did not significantly influence 1) the Mtb-specific CD4 T-cell functional profiles (P>0.05) (Fig
6E), 2) the nature and the amount of Th2 cytokines produced i.e. IL-4 and/or IL-5 and/or IL-
13 (P>0.05) (S6A Fig) and 3) the transcription factor profile of TB and Mtb/helminth infected
patients from TZ (P>0.05) (S6B Fig). Indeed, two months after TB treatment, the cytokine
profile of Mtb-specific CD4 T cells was still dominated by polyfunctional IFN-γ/IL-2/TNF-α
and Th2 Mtb-specific CD4 T cells (Fig 6E).
In summary, two months of TB treatment did not change the functional profile of Mtb-spe-
cific CD4 T cells. These data provide evidence that TB treatment outcome during this follow
up period was not influenced by presence or absence of ongoing helminth infection.
Discussion
Helminth infections have been shown to impact the control of virus replication in mouse mod-
els [52, 56] and interfere with vaccine induced immune responses [57, 58]. Since helminths
and Mtb are co-endemic in several regions of the world, including Tanzania [1], we hypothe-
sized that ongoing helminth infection may influence and potentially modulate the functional
profile of Mtb-specific T-cell responses. Our hypothesis is founded on the observations that
helminths stimulate Th2 type immune responses and previous studies that demonstrated that
the cytokine micro-environment may influence, at least in vitro, the functional profile of anti-
gen-specific CD4 T cell responses [59, 60].
Table 2. Contribution of the major differentially expressed immune parameters discriminating Mtb-specific immune signatures of TB patients
from TZ and SA identified by principal component analysis.
Axes Variance (%) Immune parameters Correlation P value
Dim1 36.6% T-bethigh 0.827 3.4E-19
Dim1 36.6% IFN-β 0.767 3.9E-15
Dim1 36.6% IFN-γ 0.635 2.1E-09
Dim1 36.6% IFN-γ/TNF-α 0.277 0.018
Dim1 36.6% IL-5 -0.284 0.018
Dim1 36.6% IFN-γ/TNF-α/IL2 -0.303 0.010
Dim1 36.6% Gata-3 -0.800 3.5E-17
Dim2 18% IFN-γ/TNF-α 0.835 7.5E-20
Dim2 18% IFN-γ/TNF-α/IL2 0.670 1.2E-10
Dim2 18% IL-5 -0.302 0.010
Dim3 15% IL-5 0.838 4.2E-20
Dim3 15% IFN-γ/TNF-α/IL2 0.483 1.7E-05
Dim3 15% Gata-3 -0.288 0.014
Abbreviations: T-bethigh, percentage of memory CD4 T cells expressing high level of T-bet; IFN-β, serum level of IFN-β; IFN-γ, proportion of single IFN-γ
producing Mtb-specific CD4 T cells; IFN-γ/TNF-α, proportion of dual IFN-γ/TNF-α producing Mtb-specific CD4 T cells; IL-5, level of IL-5 detected in
supernatants of Mtb-stimulated cell cultures; IFN-γ/TNF-α/IL-2, proportion of polyfunctional IFN-γ/TNF-α/IL-2 producing Mtb-specific CD4 T cells; Gata-3,
percentage of memory CD4 T cells expressing Gata-3.
https://doi.org/10.1371/journal.pntd.0005817.t002
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Fig 6. Influence of ongoing helminth infection on TB treatment efficiency. (A) Proportion of TB patients (n = 20) and Mtb/helminth (n = 24) co-
infected patients with detectable Mtb prior to and following 60 days of TB treatment. Impact of TB treatment initiation on BMI (B), serum levels of CRP
(C) and serum levels of IL-1α, IL-6 and IL-1β (D) of TB (n = 20) and Mtb/helminth (n = 22) co-infected patients from TZ prior to and following 60 days of
TB treatment. Red and green circles represent TB and Mtb/helminth co-infected patients from TZ, respectively. (E) Functional profile of Mtb-specific
CD4 T cells of TB patients (n = 20) and Mtb/helminth (n = 24) co-infected patients from TZ prior to and following 60 days of TB treatment. Blue, red,
green and orange circles represent the proportion of Mtb-specific CD4 T cells producing TNF-α, IFN-γ, IL-2 and/or IL-4/5/13 in untreated TB patients, 60
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In the present study, we provide evidence that a significant proportion of Mtb-specific CD4
T cells in patients with active TB disease from TZ have a Th2 cytokine profile as indicated by
the production of IL-4/IL-5/IL-13 and expression of the Th2 cell lineage transcription factor
Gata-3. Mtb-specific CD4 T-cells comprised Th1 and Th2 cells with a polyfunctional cytokine
profile, and the increased frequency of Gata-3+ memory CD4 T cells was associated with
reduced frequency of T-bethigh+ memory CD4 T cells. Interestingly, Mtb-specific CD4 T cells
in patients with active TB disease from SA had a typical Th1 profile encompassing single IFN-
γ and dual IFN-γ/TNF-α cells. Taken together, these results demonstrate that active TB disease
induced the generation of mixed Th1/Th2 Mtb-specific CD4 T cells in patients from TZ
whereas a typical Th1 Mtb-specific CD4 T cell response was generated in patients from SA.
Further investigations would be needed to determine whether TB-uninfected individuals from
TZ and SA harbor different basic response to TB antigens.
These observations are of high interest since the assessment of Mtb-specific CD4 T-cell
cytokine profile is consistently proposed to allow the discrimination between active and latent
Mtb infections [61–64]. Among, these parameters, high proportions of IL-2-producing Mtb-
specific CD4 T cells (in association with Th1 cytokines i.e IFN-γ and/or TNF-α) are associated
with individuals with LTBI and therefore Mtb containment, while high proportion of Mtb-
specific CD4 T cells producing Th1 cytokines in absence of IL-2 is associated with patients suf-
fering from active TB disease [62–65]. Indeed, reduced capacity to produce IL-2 is usually
associated with high antigen load, persistent T-cell stimulation, expression of co-inhibitory
molecules and differentiation towards effector memory and/or terminally differentiated effec-
tor memory [66, 67]. Interestingly, CD4 T cells coexpressing IFN-γ and TNF-α and harboring
a phenotype of effector-memory response were associated with active tuberculosis in HIV-
uninfected [68, 69] and HIV-infected TB patients [67]. Of note, polyfunctional helminth-spe-
cific CD4 T-cell responses were also recently associated to helminth biological activity [47, 70].
As mentioned above, the study hypothesis was that helminth infection might influence
the functional profile of Mtb-specific CD4 T cells. In this context, about 67% of patients from
TZ either had an ongoing active helminth infection or had evidence of previous helminth
exposure/infection. However, about 11% of the patients from SA also showed a positive serol-
ogy for previous helminth exposure/infection with helminth but no sign of generation of Mtb-
specific Th2 CD4 T cells. Despite this discordance between positive serology for helminth
exposure and lack of the generation of Mtb-specific Th2 CD4 T cells in patients from SA,
we cannot exclude that the frequency and/or severity of helminth re-infection/exposure in
patients from TZ is higher as when compared to South African patients and therefore re-
sponsible for the mixed Th1/Th2 functional profile of Mtb-specific CD4 T cells [71, 72]. In
addition, we cannot exclude that human or Mtb genetic diversity and other yet unknown envi-
ronmental factors may contribute to the generation of mixed Th1/Th2 functional cytokine
profile and/or influence the durability of the Th2 response after parasite infection is cleared
[73] in patients from TZ.
Consistent with previous studies [53, 74], about 80% of TB patients from TZ had Mtb-spe-
cific CD8 T cell responses detected by polychromatic flow cytometry. Interestingly, this pro-
portion was significantly reduced (about two fold) in the presence of ongoing helminth
days treated TB patients, untreated Mtb/helminth co-infected patients and 60 days treated Mtb/helminth co-infected patients recruited from TZ,
respectively (E). TB patients were color coded; untreated TB patients, blue; treated TB patients, red; untreated Mtb/helminth co-infected patients,
green; treated Mtb/helminth co-infected patients, orange. Red arcs identify IL-4/5/13 producing cell populations (E). Red stars indicate statistical
significance (* = P<0.05). Statistical significance (P<0.05) was calculated using Chi square test (A), Wilcoxon signed-rank test (B and C) and one way
Anova Kruskal-Wallis test followed by a Mann-Whitney test (D). Statistical analyses of the global cytokine profiles (pie charts, E) were performed by
partial permutation tests using the SPICE software as described [97].
https://doi.org/10.1371/journal.pntd.0005817.g006
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infections. These results provide additional evidence that helminth infections may significantly
influence the generation of distinct T cell subsets in active TB disease. This important finding
echoes with recent data demonstrating that ongoing helminth infection impairs virus-specific
T-cell immunity via a STAT-6-dependent alternative activation of macrophages differentiation
[52].
In contrast to Tanzanian TB cases, the South African TB patients were characterized by sig-
nificantly higher serum levels of pro-inflammatory cytokines (IL-1α and TNF-α) in combina-
tion with IL-12p70 and type I IFNs. Interestingly, statistical analyses revealed that elevated
serum levels of IFN-β were associated with elevated serum levels of pro-inflammatory cyto-
kines and Th1 Mtb-specific CD4 T cells lacking IL-2 co-production. These IFN-β serum levels
were inversely correlated with polyfunctional Mtb-specific CD4 T cells and Th2 cytokines
detected by polychromatic flow cytometry and in cell culture supernatants. Based on these
findings, the so far unappreciated role of IFN-β (and type I IFNs in general) in coordinating
TB specific immunity needs to be further explored.
The role of Th1, Th2 and CD8 T cells in the control of Mtb infection and the progression
of TB disease is under intense debate. It has been clearly demonstrated that functional impair-
ment of the IL-12p70/IFN-γ axis predisposes to the development of mycobacterial disease [7–
10], probably by compromising the phagocytic and cytolytic capacity of macrophages primed
with IFN-γ [75]. The role of Mtb-specific CD8 T cells is however still controversial. Some stud-
ies indicate that Mtb-specific CD8 T cells may play an important role in protective immunity
against TB via the production of perforin and/or cytolysin [76–80], while others indicate that
the presence of Mtb-specific CD8 T cells may be detrimental [81], since Mtb-specific CD8 T
cells were enriched in TB patients as compared to individuals with LTBI [53]. Excessive IFN-γ
production by CD4 or CD8 T cells may in fact favour Mtb transmission via inflammation
mediated mucosal damage enabling access of Mtb bacilli to airways [81].
The dual role of IFN-γ in the protection or progression of TB disease may be linked to mac-
rophage hypo-responsiveness to IFN-γ [82], also called progressive exhaustion, which can be
mediated by Mtb-induced type I IFNs [83, 84]. Indeed, recent studies demonstrated that Mtb-
induced type I IFN might be detrimental, since TB patients with reduced/absent type I IFN sig-
nature had reduced bacterial load and/or improved host survival [85–87]. Interestingly, other
studies indicate that type I IFN responses enhance CD4 T-cell differentiation towards Th1
[88], enhance CD8 T-cell responses [89] and interfere with IL-23-mediated Th17 cell differen-
tiation and IL-4-mediated Th2-cell differentiation by inhibiting Gata-3 expression [88, 90, 91],
supporting our observations.
The reason why TB patients from TZ had lower levels of type I IFNs remains unclear and
needs to be further investigated. However, one could postulate that the genetic background of
the Mtb strains isolated from TZ and SA, the antigen load and the genetic background of the
individuals living in TZ versus SA might be associated with this profile, since the level of Mtb-
induced type I IFN production might be strain dependent [92]. Of note, these parameters were
not evaluated in the present study and would require further evaluation.
Finally, we did not observe any influence of ongoing helminth infection on the efficacy of
TB therapy. Interestingly, after sixty days of treatment, we did not observe changes in Mtb-spe-
cific CD4 T-cell cytokine and transcription factor expression profile but strongly reduced CRP
serum levels and pro-inflammatory cytokine circulation in combination with improved BMI.
In conclusion, we provide evidence that the generation of Mtb-specific CD4 and CD8 T cell
responses, may be substantially influenced by co-infectious agents and possibly genetic and
environmental factors resulting in pronounced variations in the qualitative and quantitative
profile of pathogen-specific responding T cells in human populations.
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Materials and methods
Study group, helminth diagnosis and cell isolation
In total, 72 subjects were recruited to participate in this study. No statistical method was used
to predetermine sample size. Fifty-five subjects were recruited at the Mwananyamala Hospital,
Dar es Salaam, and the TB clinic of Bagamoyo (TZ). TB patients (n = 55) were selected based
on sputum smear microscopy confirmed by GeneXpert assay and HIV infection was ruled out
by rapid serological test (Alere Determine HIV-1/2 test). The diagnosis of ongoing and/or past
helminth infection was based on assays performed on feces (Kato-Katz thick smear, FLOTAC
and Baermann assays), urine (urine filtration), whole blood (Immuno-chromatography) and
serum (ELISA) samples at date of blood sample collection and the assay used depended on the
helminth species and on the site of sample collection. All TB patients from TZ were screened
for active soil-transmitted helminths (hookworms, Ascaris lumbricoides, Trichuris trichiura)
and S. mansoni infections using the Kato-Katz thick smear and FLOTAC methods performed
on one stool sample at date of blood sample collection, for active S. stercoralis infection using
the Baermann technique and for active S. haematobium infection using the urine filtration
method. Binax NOW ICT test card were used to detect W. Bancrofti antigen on blood sample
[93, 94]. In addition, serology for 7 different helminths (Echinococcus spp, Fasciola hepatica,
Filaria, Schistosoma spp, S. stercoralis, Toxocara spp and Trichinella spp) was performed by
ELISA. The serodiagnostic helminth screening ELISA is routinely performed at the diagnostic
centre of the Swiss Tropical and Public Health Institute and detects helminth specific IgG. A
total of 30 Mtb/helminth co-infected patients were recruited. TB patient co-infected with only
one helminth species were infected with S. mansoni (n = 7), W. bancrofti (n = 6), hookworms
(n = 2), S. haematobium (n = 2) or S. stercoralis (n = 2). Eleven TB patients (36%) were co-
infected with multiple helminth species. Blood samples were collected prior to and following
60 days of anti-mycobacterial treatment (“fixed dose combination” consisting of Rifampicin,
Isoniazid, Pyrazinamide and Ethambutol, (RHZE)) from 20 TB and 24 Mtb/helminth co-
infected patients recruited in TZ. In addition, seventeen subjects were enrolled at the field site
of the South African Tuberculosis Vaccine Initiative in the Boland Overberg region of the
Western Cape Province of SA (SA). TB disease was diagnosed by positive sputum Xpert MTB/
RIF and HIV infection was ruled out by rapid serological test. PBMCs were collected as part of
a cross-sectional study, in HIV-negative participants before commencing treatment for TB.
Diagnosis of helminth exposure was performed using ELISA detecting helminth-specific IgG
(Echinococcus spp, Fasciola hepatica, Filaria, Schistosoma spp, S. stercoralis, Toxocara spp and
Trichinella spp).
Ethics statement
All participants were adults and provided written informed consent and the study protocol
was approved for TZ by the Ethikkomission beider Basel (EKBB; Basel, Switzerland; reference
number 257/08), the Ifakara Health Institute Institutional Review Board and the National
Institute for Medical Research (NIMR; Dar es Salaam, United Republic of Tanzania; reference
number NIMR/HQ/R.8a/Vol.IX/1098). For SA, the Human Research Ethics Committee of the
University of Cape Town granted the study protocol approval.
Antibodies
The following monoclonal antibodies (mAbs) were used in different combinations.
CD3-APC-H7 (CloneSK7), CD4-PECF594 or CD4-APC (Clone RPA-T4), CD8-PB (Clone
RPA-T8), IFN-γ-AF700 or IFN-γ-APC (Clone B27), TNF-α-PeCy-7 (Clone MAb11), IL-4-PE
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(Clone 3010.211), IL-2-PE (Clone MQ1-17H12), Gata-3-PeCy-7 (Clone L50-823), all from
Becton Dickinson (BD); CD45RA-BV711 (Clone HI100), IL-2-PerCpCy5.5 (Clone MQ1-
17H12), IL-5-PE (Clone TRFK5), IL-13-PE (Clone JES10-5A2), T-bet-PerCpCy5.5 (Clone
4B10) were purchased from BioLegend; CD8-Efluor625NC (Clone RPA-T8) from eBioscience;
perforin-FITC (Clone B-D48) from Diaclone.
Antigens
Mtb-derived CFP-10 and ESAT-6 peptide pools are composed of 15-mers overlapping by 11
amino-acids encompassing the entire sequences of the proteins and all peptides were HPLC
purified (>90% purity).
Ex vivo assessment of CD4 T-cell cytokine profile by ICS
PBMCs were stimulated overnight in complete media (RPMI (Invitrogen), 10% fetal calf
serum (FCS; Invitrogen), 100 µg/ml penicillin, 100 unit/ml streptomycin (BioConcept)) with
ESAT-6 and CFP-10 peptide pools (1 µg/ml) or with Staphyloccocus enterotoxin B (SEB; 250
ng/mL) or unstimulated in the presence of Golgiplug (1 μl/ml; BD) as previously described
[95]. At the end of the stimulation period, cells were washed and stained (20 min; 4˚C) for
dead cells using the Aqua LIVE/DEAD stain kit (Invitrogen), washed and stained (20 min;
4˚C) with mAbs to CD3, CD4, CD8 and CD45RA. Cells were then permeabilized (30 min;
20˚C) (Cytofix/Cytoperm, BD) and stained (20 min; 20˚C) with mAbs to TNF-α, IFN-γ, IL-2,
IL-4, IL-5 and IL-13.
Ex vivo assessment of CD8 T-cell cytokine profile by ICS
PBMCs were stimulated overnight in complete media (RPMI (Invitrogen), 10% fetal calf
serum (FCS; Invitrogen), 100 µg/ml penicillin, 100 unit/ml streptomycin (BioConcept)) with
ESAT-6 and CFP-10 peptide pools (1 µg/ml) or Staphyloccocus enterotoxin B (SEB; 250 ng/mL)
or unstimulated in the presence of Golgiplug (1 μl/ml; BD). At the end of the stimulation
period, cells were washed and stained (20 min; 4˚C) for dead cells using the Aqua LIVE/
DEAD stain kit, then permeabilized (30 min; 20˚C) (Cytofix/Cytoperm, BD) and stained (20
min; 20˚C) with mAbs to CD3, CD4, CD8, TNF-α, IFN-γ, IL-2 and perforin.
Assessment of T-bet, Gata-3 expression
PBMCs were washed, stained (20 min; 4˚C) for dead cells using the Aqua LIVE/DEAD stain
kit, then washed and stained (20 min; 4˚C) for CD3, CD4, CD8, CD45RA. Cells were then
washed, permeabilized (45 min; 4˚C) (Foxp3 Fixation/Permeabilization Kit; eBioscience) and
stained (20 min; 4˚C) with mAbs to T-bet and Gata-3.
Assessment of Mtb-stimulated culture supernatant cytokine profile by
luminex assay
PBMCs (2x105 cells) were stimulated for 24 hours in complete media (RPMI (Invitrogen),
10% fetal calf serum (FCS; Invitrogen), 100 µg/ml penicillin, 100 unit/ml streptomycin (Bio-
Concept)) with ESAT-6 and CFP-10 peptide pools (1 µg/ml) or with Staphyloccocus entero-
toxin B (SEB; 250 ng/mL) or left unstimulated (negative control). At the end of the stimulation
period, culture supernatants were collected and levels of TNF-α, IFN-γ, IL-2, IL-4, IL-5, IL-13,
IL-10, IL-17A and IL-17F were assessed cells by luminex assay (ProcartaPlex Mix&Match
Human plex, eBioscience).
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Assessment of serum cytokine profile
Serum levels of IL-1α, IL-6, TNF-α, IL-12p70, IL-23, IL-10, IFN-α2, IFN-β, IFN-ω and IFN-γ
was assessed by luminex assay (ProcartaPlex Mix&Match Human plex, eBioscience) and CRP
was assessed by nephelemetry (CardioPhasehsCRP, Siemens Healthcare Diagnostics Products
GmbH) as previously described [96].
Flow cytometry analyses
Cells were fixed with CellFix (BD), acquired on an LSRII SORP (4 lasers: 405, 488, 532 and
633 nm) and analyzed using FlowJo (version 9.7.7) (Tree star Inc, Ashland, OR, USA). Fre-
quencies of cytokine-producing Mtb-specific T cells and cytokine profile of Mtb-specific T-cell
responses were analyzed using SPICE software (version 5.34) following background subtrac-
tion. When required, analysis and presentation of distributions was performed using SPICE,
downloaded from <http://exon.niaid.nih.gov/spice> [97].
Statistical analyses
Statistical significance (P values) was obtained either using two-tailed Chi-square analysis for
comparison of positive proportions or using one-way ANOVA (Kruskal-Wallis test) followed
by Mann–Whitney test or Wilcoxon Matched-pairs two-tailed Signed Rank test for multiple
comparisons or Spearman rank test for correlations using GraphPad Prism version 7 (San
Diego, CA). Statistical analyses of global cytokine profiles (pie charts) were performed by par-
tial permutation tests using the SPICE software as described [97]. Principal component analy-
sis (PCA) was performed using the R ‘‘stats” package. To normalize data distribution, the
values of each parameter were first log transformed. Data were then filtered using Lasso
method [98].
Supporting information
S1 Fig. Flow chart of the enrolled patients.
(PDF)
S2 Fig. Gating strategy used to assess CD4 T-cell cytokine profile.
(PDF)
S3 Fig. S. mansoni soluble egg antigen-specific CD4 T cells from TB/S. mansoni co-infected
patients from TZ. Proportion of SEA-specific CD4 T-cell responses producing IFN-γ, IL-4/5/
13, TNF-α and/or IL-2 of TB patients from TZ (n = 7). All the possible combinations of the
responses are shown on the x axis and the percentage of the functionally distinct cell popula-
tions within the SEA-specific CD4 T-cell populations are shown on the y axis. Responses are
grouped and color-coded on the basis of the number of functions. The pie chart summarizes
the data, and each slice corresponds to the fraction of SEA-specific CD4 T cell response with a
given number of functions within the responding CD4 T-cell population. Bars correspond to
the fractions of different functionally distinct CD4 T-cell populations within the total CD4 T
cells. Red arcs correspond to IL-4/5/13-producing CD4 T-cell populations.
(PDF)
S4 Fig. Influence of the helminth species, polyparasitism, helminth species harbouring
lung migration capacity and past helminth exposure on the proportion of Mtb-specific
CD4 T cells producing Th2 cytokines, on the level of Th2 cytokines secreted and on the
percentage of CD4 T cells expressing Gata-3. (A) Proportion of Mtb-specific CD4 T cells
producing IL-4/5/13 among total Mtb-specific CD4 T-cell responses assessed in TB patients
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from TZ infected with one helminth (n = 19) as compared to TB patients from TZ infected
with more than one helminth (n = 11) or (B) between TB patients from TZ infected with hel-
minth species harbouring (hookworm and S. stercoralis) or not (S. mansoni, S. haematobium
and W. bancrofti) lung migration capacity. (C) Proportion of Mtb-specific CD4 T cells produc-
ing IL-4/5/13 among total Mtb-specific CD4 T-cell responses assessed in TB patients from SA
with (n = 2) or without past helminth exposure (n = 15). (D) Proportion of Mtb-specific CD4
T cells producing IL-4/5/13 among total Mtb-specific CD4 T-cell responses assessed in TB
patients from TZ without ongoing helminth infection but with (n = 7) or without past hel-
minth exposure (n = 18). (E) Levels of IL-4, IL-5 and IL-13 secreted in Mtb-stimulated culture
supernatants in TB patients from TZ infected with one helminth (n = 19) and TB patients
from TZ infected with more than one helminth (n = 10) or (F) between TB patients from TZ
infected with helminth species harbouring or not lung migration capacity. (G) Levels of IL-4,
IL-5 and IL-13 secreted in Mtb-stimulated culture supernatants in TB patients from SA with
(n = 2) or without past helminth exposure (n = 10). (H) Levels of IL-4, IL-5 and IL-13 secreted
in Mtb-stimulated culture supernatants in TB patients from TZ without ongoing helminth
infection but with (n = 6) or without past helminth exposure (n = 15). (I) Percentage of mem-
ory CD4 T cells (CD45RA-) expressing Gata-3 of TB patients from TZ infected with one hel-
minth (n = 8) and TB patients from TZ infected with more than one helminth (n = 5) or (J)
between TB patients from TZ infected with helminth species harbouring or not lung migration
capacity. (K) Percentage of memory CD4 T cells (CD45RA-) expressing Gata-3 of TB patients
from SA with (n = 2) or without past helminth exposure (n = 10). (L) Percentage of memory
CD4 T cells (CD45RA-) expressing Gata-3 of TB patients from TZ without ongoing helminth
infection but with (n = 6) or without past helminth exposure (n = 8). Helminth species were
color coded (A, E and I); W. bancrofti, orange; hookworms, green; S. mansoni, red, S. haemato-
bium, yellow, S. stercolaris, violet, and patients infected with more than one helminth species
in light blue. Statistical significance (P<0.05) was calculated by Mann-Whitney test.
(PDF)
S5 Fig. The percentage of memory CD4 T cells expressing T-bethigh inversely correlates
with the percentage of memory CD4 T cells expressing Gata-3. (A) Correlation between the
percentage of memory CD4 T cell expressing Tbethigh and the percentage of memory CD4 T
cell expressing Gata-3 in TB patients from SA (n = 12), TB patient (n = 14) and Mtb/helminth
co-infected patients (n = 13) from TZ. TB patients were color coded; TB patients from SA,
blue; TB patients from TZ, red and Mtb/helminth co-infected patients, green. Statistical signif-
icance (P<0.05) was calculated using Spearman rank test.
(PDF)
S6 Fig. Impact of anti-mycobacterial treatment on the Th2 cytokine secretion and on tran-
scription factor expression. (A) Levels of IL-4, IL-5 and IL-13 produced in Mtb-stimulated
culture supernatants of TB (n = 13) and Mtb/helminth co-infected patients from TZ (n = 18)
assessed by luminex assay. (B) Percentage of memory (CD45RA-) CD4 T cells expressing
Gata-3 or T-bethigh of TB (n = 11) and TB/helminth co-infected patients (n = 8) from TZ. TB
patients were color coded; TB patients, red and Mtb/helminth co-infected patients, green.
(PDF)
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